SKYI · Sky Century Investment, Inc.
$0.12
-0.01 (-8.00%)
At close · Sep 1
Going-concern doubt
— flagged Jul 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These and other factors raise substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification.”View the 10-Q filed Jul 14, 2026
Market Cap
$797,579
Shares
6.94M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$76.34K
+47.4%
FY2025
Net Income
-$117.23K
-60.8%
FY2025
Gross Margin
32.07%
-1pp
FY2025
Operating Margin
-152.78%
-12pp
FY2025
Operating Cash Flow
$46.48K
+9377.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| $126.22K | $76.34K | $51.8K | — | — | |
| $59.43K | $51.86K | $34.67K | — | — | |
| $66.79K | $24.48K | $17.13K | — | — | |
| — | 32.07% | 33.07% | — | — | |
| $91.64K | $98.82K | $60K | -$4019 | -$4001 | |
| $129.25K | $141.11K | $90.05K | -$23.27K | -$17.5K | |
| -$62.45K | -$116.63K | -$72.92K | — | — | |
| — | -152.78% | -140.77% | — | — | |
| $0 | $594 | $0 | — | — | |
| $0 | -$594 | $0 | — | — | |
| -$62.45K | -$117.23K | -$72.92K | — | — | |
| $0 | $0 | $0 | — | — | |
| -$62.45K | -$117.23K | -$72.92K | -$23.27K | -$17.5K | |
| — | -153.56% | -140.77% | — | — | |
| USD/shares | $0.00 | $0.00 | $0.00 | $0.00 | — |
| shares | — | 2.23M | 2.21M | — | 60K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.07×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 19 similar-size Drug Manufacturers - Specialty & Generic companies (of 95 listed).